Internal medicine, Immunology, Virology, Hepatitis C virus and Ribavirin are his primary areas of study. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Ledipasvir, Surgery and Sofosbuvir. His work on Viral disease, Immunopathology and Virus as part of general Immunology study is frequently linked to Circulating MicroRNA, therefore connecting diverse disciplines of science.
His Virology research is multidisciplinary, relying on both Pharmacogenetics, Efavirenz and Acquired immunodeficiency syndrome. Stefan Mauss interconnects Hepatitis B, Malignancy and Hepatitis in the investigation of issues within Acquired immunodeficiency syndrome. His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Liver disease, Hepatitis C, Disease and Intensive care medicine.
Stefan Mauss mainly focuses on Internal medicine, Ribavirin, Gastroenterology, Hepatitis C and Virology. The study incorporates disciplines such as Chronic hepatitis, Immunology and Hepatitis C virus in addition to Internal medicine. His Immunology study frequently intersects with other fields, such as Acquired immunodeficiency syndrome.
In the field of Ribavirin, his study on Peginterferon alfa-2a, Hcv genotype 1, Pegylated interferon and Telaprevir overlaps with subjects such as PEG ratio. His work focuses on many connections between Gastroenterology and other disciplines, such as Adverse effect, that overlap with his field of interest in Clinical trial. His research integrates issues of Surgery, Cirrhosis, Viral load, Sofosbuvir and Hepatitis in his study of Hepatitis C.
His primary scientific interests are in Internal medicine, Hepatitis C, Hepatitis C virus, Gastroenterology and Cohort. His work in Internal medicine addresses issues such as Chronic hepatitis, which are connected to fields such as Weight gain. His Hepatitis C study combines topics in areas such as Virus, Pibrentasvir, Regimen and Glecaprevir.
Hepatitis C virus is a subfield of Virology that Stefan Mauss tackles. His Virology research integrates issues from Epidemiology and Treatment failure. His biological study spans a wide range of topics, including Elbasvir, Grazoprevir, Ribavirin, Sofosbuvir and Fibrosis.
Stefan Mauss mostly deals with Internal medicine, Hepatitis C virus, Hepatitis C, Hepatitis and Cohort. His Internal medicine research focuses on Gastroenterology and how it connects with Fibrosis. His Hepatitis C virus research is classified as research in Virology.
In his study, Immunology, Tolerability and Glecaprevir is strongly linked to Regimen, which falls under the umbrella field of Hepatitis. His studies deal with areas such as Odds ratio, Diabetes mellitus, Acquired immunodeficiency syndrome, Hazard ratio and Risk factor as well as Cohort. His Sofosbuvir course of study focuses on Ledipasvir and Clinical significance and Viral load.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel.
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.
Vincent Soriano;Mark Sulkowski;Colm Bergin;Angelos Hatzakis.
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Julie Sheldon;Nuria Camino;Berta Rodés;Angeline Bartholomeusz.
Antiviral Therapy (2005)
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
JK Rockstroh;S Bhagani;Y Benhamou;R Bruno.
Hiv Medicine (2008)
Care of patients with hepatitis C and HIV co-infection.
Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss.
Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
Vincent Soriano;Massimo Puoti;Marion Peters;Yves Benhamou.
A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance.
Stefan Mauss;Florian Berger;Joerg Goelz;Bernhard Jacob.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: